303 related articles for article (PubMed ID: 17571380)
1. [Levosimendan for treatment of heart failure].
Yasumura Y
Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
[No Abstract] [Full Text] [Related]
2. Levosimendan.
Kamath SR; Jaykumar I; Matha S
Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
[No Abstract] [Full Text] [Related]
3. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan in cardiogenic shock: the magic drug for every patient?
Smetana P; Geppert A
Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
[No Abstract] [Full Text] [Related]
5. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
Berger R; Moertl D; Huelsmann M; Bojic A; Ahmadi R; Heissenberger I; Pacher R
Eur J Heart Fail; 2007 Feb; 9(2):202-8. PubMed ID: 16859992
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
7. What is the in vivo mechanism of action of levosimendan?
MacGowan GA
J Card Fail; 2005 Aug; 11(6):482; author reply 482-3. PubMed ID: 16105641
[No Abstract] [Full Text] [Related]
8. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
Laine M; Lehtonen L; Nieminen MS
Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
[No Abstract] [Full Text] [Related]
9. [Use of levosimendan in acute heart failure and its effect on renal function].
Moyano AP; Hidalgo RL; Grande DB; Morales SC
Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016
[No Abstract] [Full Text] [Related]
10. Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?
Parissis JT; Farmakis D; Kremastinos DT
Eur J Heart Fail; 2006 Mar; 8(2):215; author reply 218. PubMed ID: 16442844
[No Abstract] [Full Text] [Related]
11. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
14. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
Lilleberg J; Laine M; Palkama T; Kivikko M; Pohjanjousi P; Kupari M
Eur J Heart Fail; 2007 Jan; 9(1):75-82. PubMed ID: 16829185
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
Kota B; Prasad AS; Economides C; Singh BN
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan and pulmonary hypertension.
Cavusoglu Y; Beyaztas A; Birdane A; Ata N
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
[No Abstract] [Full Text] [Related]
17. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan in the treatment of cardiogenic shock.
Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
[TBL] [Abstract][Full Text] [Related]
19. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.
Parissis JT; Adamopoulos S; Antoniades C; Kostakis G; Rigas A; Kyrzopoulos S; Iliodromitis E; Kremastinos D
Am J Cardiol; 2004 May; 93(10):1309-12. PubMed ID: 15135713
[TBL] [Abstract][Full Text] [Related]
20. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
